Cambridge Investment Research Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 6,804 shares of IONS stock, worth $280,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,804
Previous 7,765
12.38%
Holding current value
$280,120
Previous $271,000
24.35%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA16.4MShares$675 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$666 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$509 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$347 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.84B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...